Drugs / A1G4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00003023 | Mar 1997 → Jan 2005 | neuroblastoma, sarcoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A1G4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003023 ↗ |
| Modality | Monoclonal antibody | “anti-idiotypic rat monoclonal antibody A1G4” NCT00003023 ↗ |